Ampio Pharmaceuticals, Inc. announced that Mike Macaluso is taking a one-year medical leave of absence from his role as Chairman and CEO, effective immediately. Announcement follows Mr. Macaluso's disclosure in October, 2021, that he was undergoing medical treatment. Ampio Board member Michael Martino has been appointed as Interim Chairman of the Board of Directors and CEO, effective immediately. Holli Cherevka continues in her role as President and COO.